Conference Agenda

Ajay Bhatt As the CEO of Medsource ozone Biomedicals, a leading medical device company in India, I have successfully transformed the organization from a debt-ridden and struggling entity to a profitable and growing enterprise. With over 14 years of experience in this role, I have laid system-based operations, corrected all processes and improved cash flow to fuel the momentum of growth.

My core competencies include business planning, operations management, sales, customer relationship management, and team development. I have a strong track record of achieving financial targets, ensuring compliance, developing and managing distributors, and building relationships with industry stakeholders. I have a Bachelor of Science degree in Chemistry from Sardar Patel University, and I am skilled in new business development and key account management. My mission is to deliver innovative and high-quality medical devices that improve the lives of patients and healthcare providers.

My professional journey engulfs experience on Clinical Diagnostics business, Pharmaceutical business and Blood Transfusion sector sales. In my journey, I was fortunate to work with Giants like Glaxo, Bio-Rad & Novartis, having exposure to Indian markets as well as surrounding countries, geographically.

Alok A. Kumar leads the ESG & Sustainability function at Fortis Healthcare - one of the leading integrated healthcare providers of India.

Alok is a seasoned sustainability leader, having completed his PGDM from IIM Bangalore and undergraduate degree in B.Arch from IIT Kharagpur. At Fortis Healthcare, Alok is heading the ESG initiatives, and is captaining the ESG champions’ team - a cross-functional squad of passionate sustainability professionals nominated by the facility directors at each of the Fortis hospital units as ESG SPOCs. Together the team is leading focused on-ground initiatives targeting improvements in energy intensity, water intensity, and responsible bio-medical waste management at Fortis hospitals.

Prior to working with Fortis Healthcare, Alok was leading the managing director’s cell at Jindal Stainless Limited - where he was instrumental in bringing the ESG initiatives of Jindal Stainless to fruition. At JSL, Alok championed the customers’ voice in the ESG supply-chain landscape. Alok was awarded the ‘Best Trainer’ award and the ‘Super Squad’ award for his distinguished performance at JSL.

Alok has been a Tata Administrative Services officer (batch of 2013), and has served various teams in Tata Communications, Tata Housing, Tata chemicals, and Tata sons, leading a wide spectrum of responsibilities. Alok was awarded the ‘Blue Ribbon’ award, the ‘Whatever it takes’ award and the ‘Xtra Mile’ award for his praiseworthy performance at Tata Communications Limited.

Notably, in the aftermath of the 2013 Uttarakhand flooding disaster, Alok was a part of a specialized reconstruction and rehabilitation team of Tata Sons, operating on ground, based out of Dehradun and Rudraprayag, Uttarakhand.

Alok closely follows the evolving ESG and BRSR landscape in India, and has published many articles on the nuances of climate disclosures and climate financing. Alok identifies himself as a problem-solver and ardently promotes green technology adoption.

Captain Baban Rai served in the Army Medical Corps for 34 years, from November 1975 to December 2009, holding various technical and administrative roles. He also served as an active Paratrooper from 1984 to 1990. Following his retirement from the Army Hospital RR Delhi in December 2009, he assumed the position of Head of Department for Central Sterile Service s Department (CSSD) at the Indian Spinal Injuries Centre in March 2010. In addition to his routine CSSD responsibilities, he oversaw the procurement and billing of implants for patients.

Further More, Captain Rai currently serves as the President of the Indian Sterilization Healthcare Association (ISHA), a non-governmental organization dedicated to educating healthcare professionals about Sterile Services. ISHA conducts conferences, workshops, and lectures nationwide aimed at training and updating sterile service professionals. The organization actively advocates for the interests of central sterile professionals and presents constructive suggestions to government agencies. ISHA aspires to elevate Indian sterile services to international standards and remains committed to realizing this vision through continuous efforts.

EDUCATION -:

• BSc, MA, MBA Healthcare.
• Certificate in NBC (Nuclear, Biological and Chemical warfare).
• Diploma in OTT, CRCST (IAHCSMM).
• Certified Internal Auditor NABH.

Mr. Chirag Joshi is a Bachelor in Pharmacy from Rajiv Gandhi University, Bangalore. He has done his master’s degree in Business Administration with Specialization in Marketing from University of WALES, London (U.K).

He has completed certification program from IIM, Ahmedabad.

He joined the company in 2013, today he is the youngest CEO of Beacon Group. He is responsible for all business operations of Beacon Diagnostics which includes Export Business in 90+ countries.

He is a President of Young Leaders Council (YLC), affiliated with All India Management Association (AIMA).

He is a Treasurer of Association of Diagnostics Manufacturer of India.

Previous Position

• Director Ctvs Max Superspecialty Hospital Mohali (1st July 2014 Till June 2017).
• Additional Director Ctvs(April 2012 To July 2014) Department Of Cardiovascular And Thoracic Surgery,fortis Hospital, Mohali, Punjab, (India).
• Executive Director And Head Cardiac Sciences Ivy Healthcare Mohali Punjab India (1st July 2017 To 30th June 2019).
• Senior Consultant Ctvs Fortis Hospital Mohali (April 2008 To March 2012).
• Consultant Ctvs Fortis Hospital Mohali (April 2006 To April 2008 ).
• Associate Consultant Fortis Hospital Mohali (April 2003 To March 2006).
• Senior Asst Consultant Fortis Hospital Mohali(Nov 2001 To March 2003).

Experience In CTVS

Experience of more than 6000 Cardiovascular and Thoracic Surgeries including more than 5000 OPCAB surgeries with experience of more than 2500 Off Pump CABGs in high risk patients including acute MI , Ischemic Heart Failure and Cardiogenic shock .Other cardiac surgeries include Closure of septal defects, Valve Surgeries, Pericardectomies, mitral valvotomies, PDA closure . Keen interest in thoracic surgeries including, Thoracic trauma, LungResections/lobectomy/pneumonectomy,Decortications,Thymectomies.

A doctor turned into healthcare leadership profile, I have been handling large sized, best-known healthcare organizations, for nearly 20 years now.

Currently I am Executive Vice President with Max Healthcare and in past have been associated with groups like Fortis, Artemis, Columbia Asia, BLK, Aakash Healthcare etc, where I have been in the top bracket roles like Group COO, COO, Zonal Director, General Manager, Medical Director, etc.

Being a doctor, I bring the right balance between a business maximiser & a clinician’s mind & hence been able to get some best of the results both quality, and business wise.

Over the years, I have been able to create an identity for establishing few simple yet powerful tools and techniques and processes across the industry that have helped many organizations, both internally as well as externally, in both positioning as well as business wise.

Few Key Achievements -:

• Authored my first book “Unlocked –access your trapped, try potential to succeed by identifying the Godfather within” which has been a source of inspiration for many budding leaders, and been included in some of the professional universities for their management students.
• Delivered many motivational & business talks at some of the prestigious platforms like Indian Institute Technology (IIT, Delhi), Indian Institute of Managements (IIM), Indian School of Business (ISB), Aligarh Muslim University (AMU), Chitkara University, Delhi University, etc, to name a few.
• Have been a TEDx Speaker.
• Winner of many awards including Dr APJ Kalam Award as a Outstanding Healthcare Business Leader & Innovator.
• A certified Bullet Proof Manager (BPM), certified by Crestcom, USA.
• A certified NLP expert.

Healthcare Leadership Certification from Indian School of Business.

Founder, Medical Director & Head of Department of Minimal Access, Bariatric, Laser & General Surgery, SNH.

Being a doctor, I bring the right balance between a business maximiser & a clinician’s mind & hence been able to get some best of the results both quality, and business wise.

Chairman & Course Director, Sehgal Minimal Access Surgery Training Institute (SMASTI).

Secretary AHPI (Delhi State Chapter), State Coordinator (Reimbursement CGHS & other schemes).

Finance Secretary, CAHO Central – Core Committee.

Dr. Rajeev Gautam is a passionate biotechnologist with 30+ years of experience in the corporate sector. He has a successful, proven track record of managing sales and business strategy of renowned organizations like Cadila Pharmaceuticals, Ranbaxy Laboratories and Bremer Pharma, to name a few.

An alumnus of the Indian Institute of Technology (IIT) Roorkee, he is a technology enthusiast with a keen interest in the machine-to-mind revolution, through Artificial Intelligence (AI) based equipment.

Dr. Gautam has been leading the diverse businesses of HORIBA, a Japanese MNC that provides analytical tools for high-end research in the areas of Energy & Environment, Bio & Healthcare and Materials & Semiconductor. Under the visionary leadership of Dr. Gautam, HORIBA has established 3 manufacturing facilities at Haridwar, Nagpur and Pune in India, with a mission for LOCAL to GLOBAL (Make in India).

He is a recipient of multiple awards and accolades including ‘Diagnostic Icon of the Year at the National Diagnostics Innovation and Excellence Awards 2024’, ‘Best Innovation in Brand Management & Innovation Leadership Award 2023’, ‘Best Change Maker of the Year – Healthcare’ by MT India Healthcare Awards 2022 by Medgate today, ‘Visionary Leader award at the 20th Global Edition of The Original Business Leader of the Year Award 2022’, ‘Strategy Visionary Leader 2019’ by Transformance and ‘Leadership Icon of the Year 2018’ by USB Forums, to name a few.

Being an active speaker at various national and international forums, he also actively participates in industrial association sessions of – CII (Confederation of Indian Industry), FICCI (Federation of Indian Chambers of Commerce and Industry) and ASSOCHAM (Associated Chambers of Commerce and Industry).

Dr. Rajeev Gautam is a passionate human-environment wellness enthusiast. He has been participating in various CSR activities like healthcare camps, vocational skill development centers, education for all and tree plantation for both social upliftment and environmental sustainability.

An avid reader and penman, Dr. Gautam is often found scribbling poems. He also enjoys playing cricket and listening to soft music.

Dr. Sanjeev Kumar Gupta has worked in several national and international medical device companies for 25 years.

He has rich domain experience from Medical Device & IVD (all classes) industry which covers product life cycle from customer requirement to post market surveillance. He designed, implemented, and monitored ISO 13485 & Regulatory Requirements based Integrated QMS. He has worked in multicultural teams in multinationals as well as localized teams in national companies which enabled him to translate requirements into long-lasting compliances.

He is credited with first WHO-PQ of Malaria Rapid Test Product in India. He has given consultancy services to over 2 dozen companies in a short time for designing GMP facilities, QMS (ISO 13485, Schedule V, MDR-745 and IVDR-746, MDSAP and 510(k). He has trained medical device stake holders from CDSCO, industry and several Govt institutions.

He is a member on MedTech Mitra (ICMR) and BIRAC (DBT).

Consultant Nephrologist and Clinical Associate Professor of Medicine at Sheikh Shakhbout Medical City and Khalifa University.

Visiting Fellow, Abu Dhabi Investment Authority Lab (ADIA Lab).

Dr. Anwar is keen on using data-driven decision-making in healthcare and process optimization to improve overall healthcare outcomes. He spearheaded the digitalization of the End Stage Renal Disease program in SEHA and the digitalization of the Complete Acute Kidney Injury Management pipeline at SSMC and helped set up the Paired Kidney Exchange program in UAE. This work has been recognized and awarded by HIMSS, the Arab Hospitals Federation, and the Patient Safety Conference. He also was awarded the best nephrologist in the UAE by Health Magazine in 2023.

He is collaborating with colleagues from Khalifa University and Mohamed Bin Zayed University of Artificial Intelligence to develop an AI Platform, “RenAIssance” to help improve Acute Kidney Injury outcomes. Their team won the grand prize in a hackathon organized by Ericsson & UAE Ministry of Economy and their team was a semifinalist in the 3C-AI4H Bowl-Institute for Augmented Intelligence in Medicine (I.AIM), at Northwestern University, USA. In addition, he has received a Research grant from the Department of Health, Abu Dhabi .

An energetic, forward-thinking academic nephrologist, Dr Anwar has trained and worked at some of the leading academic centers in the world. He has strong experience and expertise in state-of-the-art patient care and research. He can develop strategies and build programs from scratch, enhance established programs, and establish new opportunities. He is leading many innovations in medical informatics to promote data-driven decision-making in medicine. He has experience in engaging the community, competing centers, and supporting organizations.

He supports capacity-building initiatives across the Middle East, Asia, and Africa to create a workforce to develop sustainable healthcare systems. In addition, he has developed and delivered training programs to prepare the healthcare workforce for the future of work which are first in the Middle East region like AI-guided Point of Care Ultrasound, and Continuous Renal Replacement Therapy.

With experience over three decades, Mr. Subodh Gupta is associated as a CEO of Lords Mark Microbiotech. Mr. Gupta has an expertise in leading organizations catering to healthcare and diagnostics sector in the past. A graduate of the Indian Institute of Management, Kolkata, he has successfully launched new business verticals in multinational companies, showcasing his strategic prowess. Known for his collaborative leadership style, Mr. Gupta excels in building high-performing teams and driving results aligned with organizational objectives. With a strong commitment to excellence and continuous improvement, he navigates dynamic market landscapes with ease, capitalizing on emerging trends to drive growth.

As CEO, Subodh Gupta envisions a future where personalized genomic testing enhances healthcare, empowering individuals to proactively manage their well-being. His collaborative leadership style and commitment to innovation position Lords Mark Microbiotech as a leader in genomic testing, poised to transform the healthcare landscape.

Dr. Sunil K Khetarpal is currently working as Director, Association of Healthcare Providers (India) and works closely with key stakeholders including Government and society. Dr. Khetarpal has also worked as COO with Rajiv Gandhi Cancer Institute, Max Healthcare, Delhi Heart and Lung Institute, Sir Ganga Ram Hospital, Indian Spinal Injuries Centre, and Shalby hospitals, among other organizations.

Dr. Sunil K. Khetarpal is an expert in healthcare management with more than 35 years of rich experience in a wide range of fields, including Hospital Administration, Clinical and Non-clinical operations, Strategy and policy development, NABH and Quality accreditation, Education and Training, Digital Health, Pharmaceuticals, MedTech, Medico-legal issues, Advocacy with the government, regulatory bodies and other stakeholders, Project Handling* and Consulting and Mentoring roles. He has been the principal assessor for NABH and also an external assessor for NQAS. In pursuit of learning, Dr Khetarpal is pursuing a certified course in digital health offered jointly by IIM Raipur and Academy of Digital Health.

He is an effective and enthusiastic speaker at national and international forums (such as GAPIO, Hospital Management Asia (HMA) at various countries) and has been a speaker/moderator/Chair/Cochair & also chief guest or guest of honor at various regional and national events. He has been an esteemed jury for Healthcare Excellence Awards organized by FICCI, Economic Times Health, Elets, ASSOCHAM, Business World Health, (IHW) Integrated Health and Wellness, and FE (Financial Express).

He is the Chief editor of AHPI Newsletter and has been on Expert Advisory Board for the review of books on Medical Law, Violence on Healthcare Professionals, Elderly care and Healthy Lifestyle published by AHPI in association with industry stakeholders.

Dr Khetarpal is an advisory board member of various medical and allied associations. He has expertise in developing roadmaps and strategies for the organization consistently producing highvalue results.

Awards & Recognitions

“Honorary IMA Professor” by IMA (Indian Medical Association),

““Best Hospital Administrator Award” ” by Dr. Abdul Kalam, the then President of India,

“Vishisht Chikitsa Ratan Award” by Delhi Medical Association on Doctor’s Day 2018,

“Special Award in Recognition of Distinguished Service to Society” by IMA-DNZ on Doctors’ Day 2023 and Annual Day of IMA-DNZ among others),

Mr. Thomas John is the Managing Director of Agappe Diagnostics Ltd, He is also the Chairman of Audit Committee and Chairman of Corporate Social Responsibility Committee.

Thomas John had completed his Engineering in Electronics & Communications from Mangalore University. After acquiring his Engineering Degree, he did his MBA from Wellington Institute, Mumbai. He has also attended an Executive Training Course from the Harvard University’s Mumbai Branch in 2011. Presently he is pursuing E-MBA specialized in Owner/President Management Program (OPM) from Harvard Business School, Boston, USA.

Thomas John started his career as a Production Engineer in equipment production with M/s. Transasia Bio-Medicals Ltd., Mumbai. Further his entrepreneurial skills combined with his ambition to do bigger things in life led him to start a business of his own along with his family members as co-promoters. Thus, Agappe Diagnostics was born in 1995 in a factory premises in Mumbai.Under the leadership of Thomas John, Agappe is now the fastest growing IVD company with more than 950 strong workforces pan India and abroad. Agappe cater to pan-India and over 90 countries across the globe.

He has been bestowed with various awards under widely recognized Magazines and platforms for his role in guiding Agappe and his exemplary performance in business.

• Future Medicine Business Excellence Award for Healthcare Entrepreneur during Emerging Kerala Business Conclave and Awards 2015.
• Emerging Entrepreneur of the Year” award during the annual conference of TiE Kerala.
• “100 Most Impactful Healthcare Leaders – Talent Listing Globally”.
• “Entrepreneur of the Year” award by Dhanam Business Magazine.
• Visionary CEO of the Year 2017” by the Jury on 10th Annual Pharmaceutical Leadership Summit & Healthcare business leadership awards 2017.

Agappe has a strong presence in segments like Clinical Chemistry, Immuno Chemistry, Haematology, Immunology (CLIA) etc. Further Agappe has its presence in POC Testing, Molecular Diagnostics, Urine Chemistry Coagulation also.Agappe launched first ever indigenously manufactured 3-Part Hematology analyzer, Mispa Count X.Mr. Thomas strives to keep Agappe in the No.1 position is something which industry is eagerly evaluating. Now Agappe has completed its 28th year of business success in Indian and the global market.

Research Interest -: In Vitro Diagnostics – Rapid, ELISA and Molecular.

Rapid TB Diagnostics, Covid-19 diagnostics, CRISPR Based Diagnostics, Real Time Screening and Monitoring of Child Malnutrition, AI tools for screening of Covid-19 and TB .

Funding Received for Ostic Pharma Pvt Ltd (Startup) -:

• Nidhi 4 Covid Grant (DST)- 35 Lacks Grants cum loan (2021) – Paper based Molecular Test for Covid-19.
• Rapid Covid-19 Tests (DST-CAWACH- 150 Lacs)- 75 Lacs Grants + 75 Lacs cum Loan (2020)- Rapid Covid Diagnostics (Rapid Covid antigen and antibody tests).
• CRISPR Based Covid-19 Tests [Indo US Science and Technology Forum (IUSSTF) - 25 Lacs each] (2020)- Covid Ignition grant - University of Florida, USA.
• Rapid TB Tests (DST SEED Grant) (2019)- 20 Lacs.
• Project investigator (Co-I) with Brazil for grant under BRICS countries (May, 2020- 2.0 Cr).
• DST- Nidhi Prayas- 2.55 Lacs for Prototype Development (2019) -2.55 Lacs.

Grant Recipient as CO-PI - IIT Bombay -:

• On TB Therapeutics: (2.0 Crore: March, 2017- Dec, 2020): India Health Fund (TATA TRUST): as a - Development of Aerosol formulations for MDR TB.
• On TB Diagnostics: (2.30 Crore: March, 2017- March, 2022): IMPRINT INDIA (MHRD & MHFW), as a co-PI- Rapid TB Tests in urine, blood and sputum with European Company, Germany.
• Centre of Excellence in Child Malnutrition under DBT Twinning program between North East States and IIT Bombay (4.88 Cr) (2021 -2022)- co-PI.

Startup Award (2022- India UK International Conference, 2022).

SARTHI Award 2022 Bill & Melinda Gates Foundation, FICCI & ADPC, 2022)-Bali, Indonesia.

Global Innovation Forum, Japan (GIF2022)- Runner up).

Asian Entrepreneurship Award, Japan (2023) Selected as Finalists.

Aarohan Social Innovation Award (Infosys Foundation – 20 Lacs)- TUMAAS Foundation (2020) – By Hon’ble Smt. Sudha Murthy ma’am and Shri Nandan Nilekani Sir.